US2019208768A1PendingUtilityA1
Compositions and method for tissue preservation
Est. expiryFeb 17, 2027(~0.6 yrs left)· nominal 20-yr term from priority
A01N 1/0226A01N 1/02A01N 1/126A01N 1/10A01N 1/122
71
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods and compositions for resuscitating, storing, and preserving functional integrity of organs and tissues. Metabolic function is maintained by sustaining ATP levels, mitochondrial function, cardiomyocyte contractility, prevention of acidosis, inhibition of induction of apoptosis, maintaining ionontrophy and lusiotrophy by regulating calcium, sodium, potassium and chloride ions.
Claims
exact text as granted — not AI-modified1 . A physiological salt solution comprising glutathione, ascorbic acid, arginine, citrulline, adenosine, creatine, glucose, carnitine and dichloroacetate.
2 . The solution of claim 1 further comprising insulin.
3 . The solution of claim 1 , wherein the glutathione is present at a concentration of 0.01-0.75 g/L.
4 . The solution of claim 1 , wherein the ascorbic acid is present at a concentration of 0.01-0.5 g/L.
5 . The solution of claim 1 , wherein the glucose is present at a concentration of 1.0-5.0 g/L.
6 . The solution of claim 1 , wherein the carnitine is present at a concentration of 0.20-2.0 g/L.
7 . The solution of claim 1 , wherein dichloroacetate is present at a concentration of 0.01-0.5 g/L.
8 . The solution of claim 1 , wherein the glutathione is present at a concentration of 0.01-0.75 g/L, ascorbic acid is present at a concentration of 0.01-0.5 g/L, creatine monohydrate is present at a concentration of 0.01-0.5 g/L, glucose is present at a concentration of 1.0-5.0 g/L, carnitine is present at a concentration of 0.20-2.0 g/L, and dichloroacetate is present at a concentration of 0.01-0.5 g/L.
9 . The solution of claim 1 , wherein the solution is further comprised of water and one or more of the salts selected from the group consisting of calcium chloride, potassium chloride, potassium phosphate (monobasic), magnesium chloride (hexahydrate), magnesium sulfate (heptahydrate), sodium chloride, sodium bicarbonate and sodium phosphate (dibasic; heptahydrate).
10 . The solution of claim 9 , wherein the calcium chloride is present at a concentration of 0.1-0.5 g/L.
11 . The solution of claim 9 , wherein the potassium chloride is present at a concentration of 0.25-0.75 g/L.
12 . The solution of claim 9 , wherein the potassium phosphate (monobasic) is present at a concentration of 0.01-0.5 g/L.
13 . The solution of claim 9 , wherein the magnesium chloride (hexahydrate) is present at a concentration of 0.01-0.5 g/L.
14 . The solution of claim 9 , wherein the magnesium sulfate (heptahydrate) is present at a concentration of 0.01-0.5 g/L.
15 . The solution of claim 9 , wherein the sodium chloride is present at a concentration of 5.0-10.0 g/L.
16 . The solution of claim 9 , wherein the sodium bicarbonate is present at a concentration of 0.01-0.5 g/L.
17 . The solution of claim 9 , wherein the sodium phosphate (dibasic; heptahydrate) is present at a concentration of 0.01-0.5 g/L.
18 . The solution of claim 1 , wherein the solution is comprised of water, calcium chloride, potassium chloride, potassium phosphate (monobasic), magnesium chloride (hexahydrate), magnesium sulfate (heptahydrate), sodium chloride, sodium bicarbonate and sodium phosphate (dibasic; heptahydrate).
19 . The solution of claim 18 , wherein the calcium chloride is present at a concentration of 0.1-0.5 g/L.
20 . The solution of claim 18 , wherein the potassium chloride is present at a concentration of 0.25-0.75 g/L.
21 - 38 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.